Suchergebnisse - "Tondini, Carlo"

PubPharm (142)

21

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

enthalten in: The New England journal of medicine | 2022

von Tawbi, H. | Schadendorf, D. | Lipson, E. | +120

CommentIn: N Engl J Med. 2022 Jan 6;386(1):91-92. - PMID 34986291

22

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78

23

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

24

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer : a European study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Scotti, L. | Gennari, A. | +67

CommentIn: Lancet Oncol. 2021 Jun;22(6):755. - PMID 33894836

25

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer : Final analysis of MetaPHER, a phase IIIb single-arm safety study

enthalten in: Breast cancer research and treatment | 2021

von Kuemmel, S. | Tondini, C. | Abraham, J. | +13

26

Multigene tests for breast cancer : the physician's perspective

enthalten in: Oncotarget | 2021

von Cognetti, F. | Biganzoli, L. | De Placido, S. | +9

27

Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic

enthalten in: The oncologist | 2021

von Zambelli, A. | Chiudinelli, L. | Fotia, V. | +20

28

The use of genomic tests in patients with breast cancer in Lombardy : a successful healthcare model

enthalten in: Tumori | 2021

von Pruneri, G. | Tondini, C.

29

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

enthalten in: Breast cancer research and treatment | 2021

von Kuemmel, S. | Tondini, C. | Abraham, J. | +13

30

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

enthalten in: Breast cancer research and treatment | 2021

von Kuemmel, S. | Tondini, C. | Abraham, J. | +13